IL122942A0 - Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them - Google Patents

Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them

Info

Publication number: IL122942A0
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; arabinofuranosylcytosine; beta; esters; compositions containing
Prior art date: 1995-07-25

Application number

IL12294296A

Other languages

English (en)

Original Assignee

Norsk Hydro As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-25

Filing date

1996-07-12

Publication date

1999-05-09

1996-07-12 Application filed by Norsk Hydro As filed Critical Norsk Hydro As

1999-05-09 Publication of IL122942A0 publication Critical patent/IL122942A0/xx

Links

UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 title 1
150000002148 esters Chemical class 0.000 title 1
125000004016 elaidoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])/C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
-1 trans-eicosenoyl Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Artificial Filaments (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polyamides (AREA)

IL12294296A 1995-07-25 1996-07-12 Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them IL122942A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9515279.9A GB9515279D0 (en)	1995-07-25	1995-07-25	Improved therapeutic agents
PCT/NO1996/000179 WO1997005154A1 (en)	1995-07-25	1996-07-12	Improved therapeutic agents

Publications (1)

Publication Number	Publication Date
IL122942A0 true IL122942A0 (en)	1999-05-09

Family

ID=10778247

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL12294296A IL122942A0 (en)	1995-07-25	1996-07-12	Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them
IL122942A IL122942A (en)	1995-07-25	1998-01-15	Pharmaceutical preparations containing esters of D – ß – 1 - arabinopuranosyl cytosine and some new esters of this type

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL122942A IL122942A (en)	1995-07-25	1998-01-15	Pharmaceutical preparations containing esters of D – ß – 1 - arabinopuranosyl cytosine and some new esters of this type

Country Status (25)

Country	Link
US (2)	US6316425B1 (de)
EP (1)	EP0842185B1 (de)
JP (2)	JP4372227B2 (de)
KR (1)	KR100401909B1 (de)
AT (1)	ATE207076T1 (de)
AU (1)	AU714814B2 (de)
CA (1)	CA2227533C (de)
CZ (1)	CZ291612B6 (de)
DE (1)	DE69616074T2 (de)
DK (1)	DK0842185T3 (de)
ES (1)	ES2166900T3 (de)
GB (1)	GB9515279D0 (de)
HU (1)	HU224839B1 (de)
IL (2)	IL122942A0 (de)
MX (1)	MX9800622A (de)
NO (1)	NO313985B1 (de)
NZ (1)	NZ313790A (de)
PL (1)	PL183601B1 (de)
PT (1)	PT842185E (de)
RU (1)	RU2165260C2 (de)
SK (1)	SK283003B6 (de)
TW (1)	TW434251B (de)
UA (1)	UA55389C2 (de)
WO (1)	WO1997005154A1 (de)
ZA (1)	ZA966047B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458772B1 (en)	1909-10-07	2002-10-01	Medivir Ab	Prodrugs
AU735438B2 (en) *	1996-11-12	2001-07-05	Medivir Ab	Nucleosides
JP4352115B2 (ja) *	1997-01-24	2009-10-28	クラヴィス・ファルマ・アーエスアー	ゲムシタビン誘導体
RU2207573C2 (ru) *	2001-08-27	2003-06-27	Новичков Евгений Владимирович	Способ прогнозирования продолжительности жизни больных печеночно-клеточной карциномой
US7393862B2 (en) *	2002-05-17	2008-07-01	Celgene Corporation	Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
WO2005049633A1 (en) *	2003-11-03	2005-06-02	Cognis Ip Management Gmbh	Acyl ribonucleosides and acyl deoxyribonucleosides
NO324263B1 (no) *	2005-12-08	2007-09-17	Clavis Pharma Asa	Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US8497292B2 (en)	2005-12-28	2013-07-30	Translational Therapeutics, Inc.	Translational dysfunction based therapeutics
BRPI0817234A2 (pt) *	2007-09-26	2014-09-30	Sinai School Medicine	Análogos de azacitidina e seus usos
GB0808357D0 (en) *	2008-05-08	2008-06-18	Cyclacel Ltd	Process
EP2501364A4 (de) *	2009-11-20	2012-10-24	Clavis Pharma Asa	Parenterale formulierungen aus gemcitabinderivaten
CN103108625A (zh)	2010-07-13	2013-05-15	克拉维斯制药股份有限公司	艾西拉滨衍生物的肠胃外制剂
SG10201603288XA (en) *	2012-03-28	2016-05-30	Fujifilm Corp	Salt Of 1-(2-Deoxy-2-Fluoro-4-Thio-beta-D-Arabinofuranosyl)Cytosine
US12059427B2 (en)	2018-01-15	2024-08-13	Yinuoke Medicine Science And Technology Company Ltd.	Treatments for cachexia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3894000A (en) *	1971-01-27	1975-07-08	Upjohn Co	Ara-cytidine derivatives and process of preparation
US4771056A (en) *	1985-08-29	1988-09-13	Roman Rozencwaig	Method of medical treatment with serotonin antagonists
RU2085557C1 (ru)	1991-09-30	1997-07-27	Санкио Компани Лимитед	Производные нуклеозидов пиримидина или их фармацевтически приемлемые соли и способ их получения
GB2266525A (en) *	1992-03-17	1993-11-03	Merck & Co Inc	Substituted cephalosporin sulfone compositions useful in the treatment of leukemia
GB9307043D0 (en) *	1993-04-05	1993-05-26	Norsk Hydro As	Chemical compounds
US5641758A (en)	1993-11-10	1997-06-24	Kluge; Michael	Cytarabine derivatives, the preparation and use thereof

1995
- 1995-07-25 GB GBGB9515279.9A patent/GB9515279D0/en active Pending
1996
- 1996-07-12 WO PCT/NO1996/000179 patent/WO1997005154A1/en not_active Ceased
- 1996-07-12 DK DK96926032T patent/DK0842185T3/da active
- 1996-07-12 NZ NZ313790A patent/NZ313790A/xx not_active IP Right Cessation
- 1996-07-12 CZ CZ1998163A patent/CZ291612B6/cs not_active IP Right Cessation
- 1996-07-12 AT AT96926032T patent/ATE207076T1/de active
- 1996-07-12 EP EP96926032A patent/EP0842185B1/de not_active Expired - Lifetime
- 1996-07-12 JP JP50750497A patent/JP4372227B2/ja not_active Expired - Fee Related
- 1996-07-12 SK SK80-98A patent/SK283003B6/sk not_active IP Right Cessation
- 1996-07-12 RU RU98103238/04A patent/RU2165260C2/ru not_active IP Right Cessation
- 1996-07-12 ES ES96926032T patent/ES2166900T3/es not_active Expired - Lifetime
- 1996-07-12 HU HU9900924A patent/HU224839B1/hu not_active IP Right Cessation
- 1996-07-12 AU AU66335/96A patent/AU714814B2/en not_active Ceased
- 1996-07-12 DE DE69616074T patent/DE69616074T2/de not_active Expired - Lifetime
- 1996-07-12 KR KR10-1998-0700463A patent/KR100401909B1/ko not_active Expired - Fee Related
- 1996-07-12 CA CA002227533A patent/CA2227533C/en not_active Expired - Fee Related
- 1996-07-12 IL IL12294296A patent/IL122942A0/xx active IP Right Grant
- 1996-07-12 PT PT96926032T patent/PT842185E/pt unknown
- 1996-07-12 US US08/983,483 patent/US6316425B1/en not_active Expired - Lifetime
- 1996-07-12 PL PL96324690A patent/PL183601B1/pl not_active IP Right Cessation
- 1996-07-16 ZA ZA9606047A patent/ZA966047B/xx unknown
- 1996-10-02 TW TW085111996A patent/TW434251B/zh not_active IP Right Cessation
- 1996-12-07 UA UA98020922A patent/UA55389C2/uk unknown
1998
- 1998-01-15 IL IL122942A patent/IL122942A/en not_active IP Right Cessation
- 1998-01-21 MX MX9800622A patent/MX9800622A/es not_active IP Right Cessation
- 1998-01-23 NO NO19980296A patent/NO313985B1/no not_active IP Right Cessation
1999
- 1999-11-09 US US09/435,641 patent/US6335322B1/en not_active Expired - Fee Related
2009
- 2009-07-03 JP JP2009159081A patent/JP5087052B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4372227B2 (ja)	2009-11-25
CZ291612B6 (cs)	2003-04-16
JP2002504068A (ja)	2002-02-05
HUP9900924A2 (hu)	2001-05-28
NO980296D0 (no)	1998-01-23
TW434251B (en)	2001-05-16
DE69616074T2 (de)	2002-06-06
WO1997005154A1 (en)	1997-02-13
US6335322B1 (en)	2002-01-01
JP5087052B2 (ja)	2012-11-28
PL183601B1 (pl)	2002-06-28
PL324690A1 (en)	1998-06-08
HUP9900924A3 (en)	2001-06-28
NO313985B1 (no)	2003-01-13
UA55389C2 (uk)	2003-04-15
NO980296L (no)	1998-01-23
KR100401909B1 (ko)	2004-02-14
CA2227533A1 (en)	1997-02-13
SK8098A3 (en)	1998-07-08
JP2009215326A (ja)	2009-09-24
KR19990035804A (ko)	1999-05-25
ATE207076T1 (de)	2001-11-15
SK283003B6 (sk)	2003-01-09
EP0842185A1 (de)	1998-05-20
ZA966047B (en)	1997-02-04
US6316425B1 (en)	2001-11-13
CA2227533C (en)	2007-01-09
RU2165260C2 (ru)	2001-04-20
ES2166900T3 (es)	2002-05-01
MX9800622A (es)	1998-11-30
PT842185E (pt)	2002-04-29
IL122942A (en)	2006-12-10
GB9515279D0 (en)	1995-09-20
DE69616074D1 (de)	2001-11-22
EP0842185B1 (de)	2001-10-17
DK0842185T3 (da)	2002-02-04
AU6633596A (en)	1997-02-26
NZ313790A (en)	1999-07-29
CZ16398A3 (cs)	1998-06-17
HU224839B1 (en)	2006-03-28
AU714814B2 (en)	2000-01-13

Legal Events

Date	Code	Title	Description
2007-07-06	KB	Patent renewed
2007-07-24	ERR	Corrigendum	Free format text: IN JOURNAL 9/2006 P. 3455 PATENT APPLICATION NO. 122942 GB 25.7.1995 WO 1997/05154 CORRECT PRIORITYCLAIM CORRECT INTERNATIONAL PUBLICATION NO. TO JULY 24, 2007
2007-07-24	FF	Patent granted
2007-12-03	KB	Patent renewed

Publication	Publication Date	Title
AU5278096A (en)	1996-10-16	Novel taxoids, preparation thereof and pharmaceutical compositions containing same
PL324430A1 (en)	1998-05-25	Novel inhibitors of pharnesiltransferase, their production and pharmaceutic compositions containing them
PL321710A1 (en)	1997-12-22	Novel inhibitors of farnseferase, their production and pharmaceutic compositions containing them
AU1180997A (en)	1997-07-17	Novel taxoids, their preparation and pharmaceutical compositions containing them
AU5476396A (en)	1996-12-19	Pharmaceutical compositions containing irbesartan
HUP9601698A3 (en)	2000-09-28	Pharmaceutical composition of adiabetical activity
HUP9701690A3 (en)	1998-04-28	Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same
ZA965294B (en)	1997-12-22	Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
AU6418596A (en)	1997-02-05	Compounds and pharmaceutical compositions containing them
AU7727196A (en)	1997-05-29	Oxygen generating compositions
HUP9801356A3 (en)	2000-07-28	Triciclic (2-hydroxy-2-methyl-3,3,3-trifluoropropanoyl)-amino-benzoxepine, -benzothiepine, -benzocycloheptene, -indene derivatives and pharmaceutical compositions containing them
ZA966047B (en)	1997-02-04	Therapeutic agents.
HUP9801880A3 (en)	1999-08-30	Novel cryptophycins, their use and pharmaceutical compositions containing them
GR3033591T3 (en)	2000-09-29	Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
WO1996021468A3 (en)	1996-09-12	Chemically modified interferon
AU5402896A (en)	1996-10-23	New taxoids, their preparation and pharmaceutical compositions containing same
IL99233A0 (en)	1992-07-15	Phosphonopyrrolidine-and phosphonopiperidine-containing pseudopeptides of the statin type,their preparation and pharmaceutical compositions containing them
AUPN131095A0 (en)	1995-03-16	Novel bacteriocin JG 126
IL106290A0 (en)	1993-11-15	Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
MY115795A (en)	2003-09-30	Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
IL122191A0 (en)	1998-04-05	Pharmaceutical compositions containing substituted benzopyrans
PL325170A1 (en)	1998-07-06	Bipolar forms of throwaflocacin
AU5994796A (en)	1996-12-30	Modified kojibiosides analogues
AU1180897A (en)	1997-07-17	Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HU9700437D0 (en)	1997-04-28	Substituted thiophenyl-alkenyl-carboxylic-acid-guanidid-derivatives, their production, their use as active component of pharmaceutical compositions, and pharmaceutical compositions containing them